Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BBIO
BBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BBIO News
BridgeBio Pharma's BBP-418 Receives FDA Priority Review
4d ago
seekingalpha
BridgeBio's BBP-418 Receives FDA Priority Review for LGMD2I/R9
4d ago
Newsfilter
BridgeBio Pharma Shares Drop After Downgrade by Raymond James
5d ago
seekingalpha
Cardiovascular Disease Costs Set to Skyrocket, Urgent Need for AI Solutions
May 12 2026
PRnewswire
Cardiovascular Disease Costs Surge, AI Technology Becomes Key
May 12 2026
Newsfilter
BridgeBio's Encaleret Shows Promising Phase 3 Results for ADH1
May 12 2026
Newsfilter
BridgeBio Reports New Data on Acoramidis Efficacy
May 11 2026
NASDAQ.COM
Acoramidis Shows Significant Benefits in ATTR-CM Study
May 11 2026
Newsfilter
BridgeBio Pharma Reports Strong Q1 2026 Earnings and $500M Buyback
May 08 2026
seekingalpha
BridgeBio Pharma Q1 Earnings Report Analysis
May 07 2026
seekingalpha
Brazil Approves Acoramidis for Cardiomyopathy Treatment
May 06 2026
Newsfilter
BridgeBio to Present ADH1 Study Data at European Congress of Endocrinology
May 05 2026
Newsfilter
BridgeBio to Present New Data at Heart Failure Conference
May 04 2026
Newsfilter
Pfizer Settles Patent Disputes with Generic Manufacturers
Apr 28 2026
stocktwits
BridgeBio Shares Surge 6.6% Following Pfizer Patent Settlement
Apr 28 2026
seekingalpha
New Campaign Enhances Awareness of ATTR-CM
Apr 28 2026
Newsfilter
Show More News
